Development and validation of a radiomics-based nomogram for predicting a major pathological response to neoadjuvant immunochemotherapy for patients with potentially resectable non-small cell lung cancer

INTRODUCTION: The treatment response to neoadjuvant immunochemotherapy varies among patients with potentially resectable non-small cell lung cancers (NSCLC) and may have severe immune-related adverse effects. We are currently unable to accurately predict therapeutic response. We aimed to develop a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chaoyuan, Zhao, Wei, Xie, Junpeng, Lin, Huashan, Hu, Xingsheng, Li, Chang, Shang, Youlan, Wang, Yapeng, Jiang, Yingjia, Ding, Mengge, Peng, Muyun, Xu, Tian, Hu, Ao’ran, Huang, Yuda, Gao, Yuan, Liu, Xianling, Liu, Jun, Ma, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978193/
https://www.ncbi.nlm.nih.gov/pubmed/36875128
http://dx.doi.org/10.3389/fimmu.2023.1115291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978193/
https://www.ncbi.nlm.nih.gov/pubmed/36875128
http://dx.doi.org/10.3389/fimmu.2023.1115291

Ejemplares similares